Parallax Volatility Advisers’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-852
Closed -$378K 2134
2023
Q3
$378K Hold
852
﹤0.01% 1677
2023
Q2
$369K Sell
852
-7,904
-90% -$4.44M ﹤0.01% 1746
2023
Q1
$5.2M Buy
8,756
+3,612
+70% +$2.02M 0.01% 842
2022
Q4
$2.08M Buy
5,144
+4,568
+793% +$2.14M ﹤0.01% 1383
2022
Q3
$337K Hold
576
﹤0.01% 2124
2022
Q2
$314K Buy
+576
New +$291K ﹤0.01% 2076

Other funds holding AGL

Parallax Volatility Advisers's AGL Position: Q2 2024 in Review

Parallax Volatility Advisers sold out of Agilon Health (AGL) in Q2 2024, closing a stake of 7,253 shares — an estimated $1.11M sold.

Parallax Volatility Advisers first reported a position in AGL in Q2 2022 and held it in 5 quarters. The position peaked at $1.11M in Q1 2024. 201 funds tracked by Wall St. Rank hold AGL as of Q2 2024.

  • Parallax Volatility Advisers reported no remaining Agilon Health position as of Q2 2024 after selling out during the quarter.
  • Parallax Volatility Advisers sold 7,253 Agilon Health shares in Q2 2024, an estimated $1.11M.
  • Parallax Volatility Advisers first reported a position in Agilon Health in Q2 2022 and held it in 5 quarters.
  • Parallax Volatility Advisers's Agilon Health position peaked at $1.11M in Q1 2024.
  • 201 funds tracked by Wall St. Rank held Agilon Health as of Q2 2024.

Based on Parallax Volatility Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.